In LSC and LAD, DLC1 expression was reduced 24-fold and 10-fold, respectively, while the fold reduction for DLC2 and DLC3 in both of these tumor types was less than one-half as much (Figure 2A and 2B). Here, STARD13 is linked to neoplasm.